t(10;11)‐Acute leukemias with MLL‐AF10 and MLL‐ABI1 chimeric transcripts: Specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines
- 23 July 2001
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 32 (1) , 1-10
- https://doi.org/10.1002/gcc.1160
Abstract
The recurrent translocation t(10;11) is associated with acute myeloid leukemia (AML). The AF10 gene on chromosome 10 at band p12 and MLL at 11q23 fuse in the t(10;11)(p12;q23). Recently, we have identified ABI1 as a new partner gene for MLL in an AML patient with a t(10;11)(p11.2;q23). The ABI1 is a human homologue of the mouse Abl‐interactor 1 (Abi1), encoding an Abl‐binding protein. The ABI1 protein exhibits sequence similarity to homeotic genes, and contains several polyproline stretches and a src homology 3 (SH3) domain. To clarify the clinical features of t(10;11)‐leukemias, we investigated 6 samples from acute leukemia patients with t(10;11) and MLL rearrangement and detected MLL‐AF10 chimeric transcripts in 5 samples and MLL‐ABI1 in one. The patient with MLL‐ABI1 chimeric transcript is the second case described, thus confirming that the fusion of the MLL and ABI1 genes is a recurring abnormality. Both of the patients with MLL‐ABI1 chimeric transcript are surviving, suggesting that these patients have a better prognosis than the patients with MLL‐AF10. To investigate the roles of AF10 and ABI1 further, we examined the expression of these genes in various cell lines and fresh tumor samples using the reverse transcriptase‐polymerase chain reaction method. Although AF10 was expressed in almost all cell lines similarly, the expression patterns of ABI1 were different between leukemia and solid tumor cell lines, suggesting the distinctive role of each isoform of ABI1 in these cell lines. We also determined the complete mouse Abi1 sequence and found that the sequence matched with human ABI1 better than the originally reported Abi1 sequence. Further functional analysis of the MLL‐AF10 and MLL‐ABI1 fusion proteins will provide new insights into the leukemogenesis of t(10;11)‐AML.Keywords
This publication has 29 references indexed in Scilit:
- The Molecular Genetics of Recurring Chromosome Abnormalities in Acute Myeloid LeukemiaSeminars in Hematology, 2000
- Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patientsLeukemia, 2000
- Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemiaLeukemia, 2000
- Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathwayGenes & Development, 1998
- A novel MLL-AF10 fusion mRNA variant in a patient with acute myeloid leukemia detected by a new asymmetric reverse transcription PCR methodLeukemia, 1997
- The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.Proceedings of the National Academy of Sciences, 1996
- Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.Genes & Development, 1995
- The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 geneCell, 1992
- A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemiasNature Genetics, 1992
- Clinical and hematologic characteristics in acute leukemia with 11q23 translocationsBlood, 1986